Academic literature on the topic 'Psychiatric illness'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Psychiatric illness.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Psychiatric illness"
1
Bedrick, Jeffrey D. "Mental Illness And Brain Disease." Folia Medica 56, no. 4 (December 1, 2014): 305–8. http://dx.doi.org/10.1515/folmed-2015-0012.
Full textAbstract:
Abstract It has become common to say psychiatric illnesses are brain diseases. This reflects a conception of the mental as being biologically based, though it is also thought that thinking of psychiatric illness this way will reduce the stigma attached to psychiatric illness. If psychiatric illnesses are brain diseases, however, it is not clear why psychiatry should not collapse into neurology, and some argue for this course. Others try to maintain a distinction by saying that neurology deals with abnormalities of neural structure while psychiatry deals with specific abnormalities of neural functioning. It is not clear that neurologists would accept this division, nor that they should. I argue that if we take seriously the notion that psychiatric illnesses are mental illnesses we can draw a more defensible boundary between psychiatry and neurology. As mental illnesses, psychiatric illnesses must have symptoms that affect our mental capacities and that the sufferer is capable of being aware of, even if they are not always self-consciously aware of them. Neurological illnesses, such as stroke or multiple sclerosis, may be diagnosed even if they are silent, just as the person may not be aware of having high blood pressure or may suffer a silent myocardial infarction. It does not make sense to speak of panic disorder if the person has never had a panic attack, however, or of bipolar disorder in the absence of mood swings. This does not mean psychiatric illnesses are not biologically based. Mental illnesses are illnesses of persons, whereas other illnesses are illnesses of biological individuals.
2
Richa, S., and M. Naddaf. "Perception of Psychiatry and Mental Disease Among Lebanese Non Psychiatric Doctors." European Psychiatry 24, S1 (January 2009): 1. http://dx.doi.org/10.1016/s0924-9338(09)71198-8.
Full textAbstract:
Objective:Evaluate the attitudes of non psychiatrist doctors and residents working in Hôtel-Dieu de France hospital towards mental illness and medical students of Saint Joseph University.Method:A 25-question-questionnaire about the perception of severe mental illness, of psychiatric treatments, of psychiatrists, and of psychiatry as a future career, which was distributed to Saint Joseph University medical students over the 7 years via the delegates of each class, to the doctors via their secretaries in their clinics, and personally to the residents between the period of November 27 and December 28, 2007.Results:We have found negative attitudes towards mental illness in the studied population but positive attitudes towards psychiatric treatments, psychiatry, and psychiatrists with higher scores among doctors than students towards mental illness (p = 0.0073) and towards psychiatric treatments (p = 0.0016) but no significant difference between different groups in the scores of perception of psychiatry (p = 0.78) and psychiatrists (p = 0.42). No difference was found between males and females for none of the scores.Conclusion:This study is the first of its kind to demonstrate that medical students’ attitudes are negative towards mental illness but positive towards psychiatric treatments, psychiatry, and psychiatrists during their first years of medical studies and stay the same after receiving a theoretical psychiatry course and after a clinical training in a psychiatric hospital and even when they become residents and that these attitudes become more positive when they become doctors.
3
Kendler, K. S., and A. Jablensky. "Kraepelin's concept of psychiatric illness." Psychological Medicine 41, no. 6 (September 1, 2010): 1119–26. http://dx.doi.org/10.1017/s0033291710001509.
Full textAbstract:
Emil Kraepelin fundamentally shaped our current psychiatric nosology. Although much has been written about his diagnostic formulations, less is known about his views on the fundamental nature of psychiatric illness and the goals of psychiatric nosology. We focus on his writings from 1896 to 1903 but also review his inaugural lecture in Dorpat in 1887 and his last two papers, published in 1919–1920. Kraepelin hoped for a ‘natural’ classification of psychiatric illness but realized that the level of etiologic knowledge required to undergird this effort was not feasible in his own lifetime. This did not stop him, however, from developing a pragmatic approach based on his clinical method of careful description with detailed follow-up, coupled with the available fallible tools of pathological anatomy and, by 1919, genetics and biochemistry. Kraepelin saw psychiatric disorders as multifactorial, arising from the difficult to untangle action and interaction of internal and external causes. He was aware of the problem of defining the boundaries of illness and health but knew this was not unique to psychiatry. Contrary to his stereotype, he was sensitive to the importance of personality factors in psychiatric illness and advocated for their investigation. He also recognized the limitations of his ‘clinical method’ and was especially critical of classifications based on single prominent symptoms. Ultimately, Kraepelin was a skeptical realist when it came to psychiatric nosology. His goal of developing a consistent ‘natural’ classification of the major mental disorders has yet to be attained, but his ‘research agenda’ remains central to psychiatry to the present day.
4
Krupinski, Jerzy. "Social Psychiatry and Sociology of Mental Health: A View on Their Past and Future Relevance." Australian & New Zealand Journal of Psychiatry 26, no. 1 (March 1992): 91–97. http://dx.doi.org/10.3109/00048679209068313.
Full textAbstract:
The origins of social psychiatry can be traced to the age of enlightenment and to the effects of the industrial revolution. Social psychiatry deals with social factors associated with psychiatric morbidity, social effects of mental illness, psycho-social disorders and social approaches to psychiatric care. Since the end of World War II up to the early seventies it has been claimed that social psychiatry should concentrate on the fight against war, poverty, racial discrimination, urban decay and all other social ills affecting people's mental health, and that the psychiatrist should be responsible for the mental health of the society. In contrast, sociology of mental health questioned the expertise of the psychiatrist and the very existence of mental illness, claiming that it covers deviant behaviour rejected by the society. The paper refutes this approach indicating that not the existence but the perception and presentation of psychiatric illness are socially determined. Acknowledging the contribution of sociology and social sciences to psychiatry, it is suggested that the heroic period of social psychiatry and the iconoclastic approach of sociology of mental health are over. However, social psychiatry, enriched by the use of epidemiological methods, has still much to offer to the daily practice of psychiatry.
5
Jackson, Cherry W. "Movies and mental illness: A psychiatry elective for third year pharmacy students." Mental Health Clinician 2, no. 10 (April 1, 2013): 314–18. http://dx.doi.org/10.9740/mhc.n143595.
Full textAbstract:
Psychiatric illnesses are common and pharmacists need to be able to recognize the signs and symptoms of the illnesses and know how they are appropriately treated. Not all pharmacy students will have an opportunity to intern in a psychiatric setting during their fourth year, and there is not adequate time in the course of a problem based learning (PBL) therapeutics curriculum to teach many of the psychiatric illnesses and their treatment. This article describes an elective course in psychiatry offered to third-year pharmacy students, which incorporates the viewing of movies and reading of books related to psychiatric illness, in order to allow students to develop a working knowledge of basic and advanced therapeutic issues related to psychiatry and psychopharmacology.
6
Andrew, Melissa K., and Kenneth Rockwood. "Psychiatric Illness in Relation to Frailty in Community-Dwelling Elderly People without Dementia: A Report from the Canadian Study of Health and Aging." Canadian Journal on Aging / La Revue canadienne du vieillissement 26, no. 1 (2007): 33–38. http://dx.doi.org/10.3138/8774-758w-702q-2531.
Full textAbstract:
ABSTRACTWe investigated whether frailty, defined as the accumulation of multiple, interacting illnesses, impairments and disabilities, is associated with psychiatric illness in older adults. Five-thousand-six-hundred-and-seventy-six community dwellers without dementia were identified within the Canadian Study of Health and Aging, and self-reported psychiatric illness was compared by levels of frailty (defined by an index of deficits that excluded mental illnesses). People with psychiatric illness (12.6% of those surveyed, who chiefly reported depression) had a higher mean frailty index value than those who did not. Older age was not associated with higher odds of psychiatric illness. Taking sex, frailty, and education into account, the odds of psychiatric illness decreased with each increasing year of age (OR 0.95; 95% CI, 0.94–0.97). Frailty was associated with psychiatric illness; for each additional deficit-defining frailty, odds of psychiatric illness increased (OR 1.23; 95% CI, 1.19–1.26). Similarly, psychiatric illness was associated with much higher odds of being among the most frail. These findings lend support to a multidimensional conceptualization of frailty. Our data also suggest that health care professionals who work with older adults with psychiatric illness should expect frailty to be common, and that those working with frail seniors should consider the possible co-existence of depression and psychiatric illness.
7
Pearson, Geraldine S. "Terminal Psychiatric Illness." Perspectives in Psychiatric Care 49, no. 2 (April 2013): 73–74. http://dx.doi.org/10.1111/ppc.12015.
Full text
8
Meyers, Derek. "Compensable Psychiatric Illness." Medical Journal of Australia 158, no. 8 (April 1993): 647. http://dx.doi.org/10.5694/j.1326-5377.1993.tb137644.x.
Full text
9
Thapa, Arati, Mukesh Karki, and Aradhana Thapa. "Vitamin-D Deficiency among Psychiatric Outpatients Attending Tertiary Care Hospital." Journal of College of Medical Sciences-Nepal 16, no. 4 (December 31, 2020): 195–200. http://dx.doi.org/10.3126/jcmsn.v16i4.34460.
Full textAbstract:
Abstract
Background: Vitamin D deficiency is associated with various physical and mental illness. This study aimed to estimate the prevalence of vitamin D deficiency among patients with psychiatric illness who visited Psychiatry outpatient department of College of Medical Sciences and Teaching Hospital, Chitwan, Nepal and investigate association of vitamin D with clinical characteristics and psychiatric illness.
Methods: A total of 129 who attended Psychiatry OPD of College of Medical Sciences and Teaching Hospital were enrolled over a period of 4 months after taking informed written consent. Psychiatric diagnoses were established by attending psychiatrists as part of the routine assessment using ICD 10/DCR criteria. Serum vitamin D was assessed by standard method. Data was analyzed using SPSS.
Results: Among 129 participants, one hundred and seven patients (82.9%) showed vitamin D level below normal range. Thirty one (24%) had vitamin D deficiency, seventy six (58.9%) had vitamin D insufficiency and twenty two (17.1%) had normal vitamin D level. The mean level of vitamin D was 24.11± 10.19. However, there was no significant association noted between vitamin D state and socio demographic profile and psychiatric illness.
Conclusions: We have found a high percentage of vitamin D deficiency among psychiatric patients in our study. Thus, screening for vitamin D deficiency should be considered as an important part of assessment of patients with major psychiatric illnesses.
10
Kelly, Brendan D., Pat Bracken, Harry Cavendish, Niall Crumlish, Seamus MacSuibhne, Thomas Szasz, and Tim Thornton. "The Myth of Mental Illness: 50 years after publication: What does it mean today?" Irish Journal of Psychological Medicine 27, no. 1 (March 2010): 35–43. http://dx.doi.org/10.1017/s0790966700000902.
Full textAbstract:
AbstractIn 1960, Thomas Szasz published The Myth of Mental Illness, arguing that mental illness was a harmful myth without a demonstrated basis in biological pathology and with the potential to damage current conceptions of human responsibility. Szasz's arguments have provoked considerable controversy over the past five decades. This paper marks the 50th anniversary of The Myth of Mental Illness by providing commentaries on its contemporary relevance from the perspectives of a range of stakeholders, including a consultant psychiatrist, psychiatric patient, professor of philosophy and mental health, a specialist registrar in psychiatry, and a lecturer in psychiatry. This paper also includes responses by Professor Thomas Szasz.Szasz's arguments contain echoes of positivism, Cartesian dualism, and Enlightenment philosophy, and point to a genuine complexity at the heart of contemporary psychiatric taxonomy: how is ‘mental illness’ to be defined? And by whom? The basis of Szasz's doubts about the similarities between mental and physical illnesses remain apparent today, but it remains equally apparent that a failure to describe a biological basis for mental illness does not mean there is none (eg. consider the position of epilepsy, prior to the electroencephalogram). Psychiatry would probably be different today if The Myth of Mental Illness had not been written, but possibly not in the ways that Szasz might imagine: does the relentless incarceration of individuals with ‘mental illness’ in the world's prisons represent the logical culmination of Szaszian thought?In response, Professor Szasz emphasises his views that “mental illness” differs fundamentally from physical illness, and that the principal habits the term ‘mental illness’ involves are stigmatisation, deprivation of liberty (civil commitment) and deprivation of the right to trial for alleged criminal conduct (the insanity defence). He links the incarceration of the mentally ill with the policy of de-institutionalisation (which he opposes) and states that, in his view, the only limitation his work imposes on human activities are limitations on practices which are conventionally and conveniently labelled ‘psychiatric abuses’.Clearly, there remains a diversity of views about the merits of Szasz's arguments, but there is little diminution in his ability to provoke an argument.
Dissertations / Theses on the topic "Psychiatric illness"
1
Corrigan, F. M. "Trace elements and psychiatric illness." Thesis, University of Aberdeen, 1987. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.592272.
Full textAbstract:
Developments in analytical techniques have allowed study of the concentrations of more than thirty elements in biological tissues. These methods have been applied to blood and brain tissues from patients with a wide range of psychiatric illness. Increases in blood vanadium concentrations in affective illness are discussed in relation to possible disturbance of noradrenaline metabolism. It is suggested that high vanadium levels may reflect high circulatory levels of noradrenaline but direct evidence of such a link has not yet been obtained. Discussions of elements in dementia centres mainly on aluminium and zinc: the possibility of low zinc concentrations being relevant becomes more likely as evidence accumulates for the role of zinc in hippocampal function. Glutamatergic transmission is likely to be crucial in this context and evidence is presented for an association between glutamate and the rare earth elements cerium and lanthanum in caudate nucleus of schizophrenics. Whether these will prove to have a fucntional role in hippocampus remains to be seen, but possible implications for modulation of striatal dopaminergic function, via glutamatergic corticostriatal tracts, are discussed. Reduction of caesium may be important through altered GABAergic transmission and reduction of indium may reflect changes in dopaminergic neuronal activity. It is considered that this work on human tissue is giving indications of which elements need to be studied in laboratory experiments to elucidate their role in neuronal transmission and, therefore, in psychiatric illness.
2
Knight, Helen Miranda. "Candidate gene studies in psychiatric illness." Thesis, University of Edinburgh, 2009. http://hdl.handle.net/1842/6508.
Full textAbstract:
Schizophrenia, bipolar disorder and major depression are common, heritable neuropsychiatric conditions and yet the source of the inherited risk remains largely unknown. This thesis focuses on two complementary strategies for identifying and characterising the genetic component of these illnesses: homozygosity mapping in consanguineous pedigrees, and genetic and neurobiological investigations of candidate genes identified by the analysis of structural chromosomal abnormalities carried by patients with psychiatric diagnoses. In a family of a cousin marriage, five of six offspring presented with a rare combination of schizophrenia, sensori-neural hearing impairment and epilepsy. Two loci were located on chromosomes 22q13 and 2p24-25 where a series of markers were homozygous by descent (HBD). Five further HBD loci were identified in a second, related family where four of five offspring had hearing loss. However, there was no overlap of the HBD intervals in the two families, and sequencing coding regions of candidate genes failed to identify causative mutations. A second study investigated the candidate gene ABCA13 identified at a breakpoint region on chromosome 7 in a patient with schizophrenia who carried a complex chromosomal rearrangement. Re-sequencing exons encoding the highly conserved functional domains identified eight potentially pathogenic, rare coding variants. Case control association studies involving cohorts of schizophrenia, bipolar disorder and major depression revealed significant associations of these variants with all three clinical phenotypes, and follow-up in relatives displayed familial inheritance patterns. Disruption of ABCA13, expressed in human hippocampus and frontal cortex, implicates aberrant lipid biology as a pathological pathway in mental illness. A third study focused on GRIK4, a candidate gene previously reported disrupted in a patient with schizophrenia who carried a chromosome abnormality. A deletion in the 3’UTR of GRIK4, encoding the kainate receptor subunit KA1, was identified as a protective factor for bipolar disorder. Using post mortem human brain tissue from control subjects, KA1 protein expression patterns were characterized in the hippocampal formation, amygdala, frontal cortex and cerebellum. KA1 expression was found significantly increased in subjects with the protective allele, supporting the hypothesis that reduced glutamatergic neurotransmission is a risk factor in major psychiatric illnesses. Together, these novel discoveries define aspects of the genetic contribution to mental illness, implicate specific dysfunctional processes and suggest new directions for research in the quest to find rationally based treatments and preventative strategies for some of the most common and disabling psychiatric disorders.
3
Al-Mutawa, Marwan S. "Psychiatric abuse and the concept of mental illness." Thesis, Swansea University, 1989. https://cronfa.swan.ac.uk/Record/cronfa42877.
Full textAbstract:
This thesis presents a critical analysis of the limitation and weakness of the concept of mental illness and proposes the Reactive Functional Disorder (RFD) approach as an alternative moral perspective on mental illness. Chapter one highlights, through an analysis of the problems of psychiatric treatment in Kuwait, the vulnerability of the concept of mental illness to abuse. In Chapter two, it is argued that the current definitional systems used in psychiatry have contributed to the vulnerability of the concept of mental illness to abuse by employing definitions which are terminologically, clinically, and morally weak. In Chapter three, the RFD approach is presented in the hope that this account might provide a deeper understanding of the moral and conceptual implications of the concept of mental illness. Chapter four provides an analysis of some of the writings of Thomas Szasz, the controversial American psychiatrist, who argues consistently that mental illness is a myth and psychiatry is unlike other well-established medical disciplines. It is argued that Dr. Szasz, in reality, is less against psychiatry than against psychiatric coercion and involuntary hospitalisation.
4
Brady, Ann Marie Brigid. "Chronic illness in childhood and adolescence : a longitudinal exploration of co-occurring mental illness." Thesis, Queen Mary, University of London, 2017. http://qmro.qmul.ac.uk/xmlui/handle/123456789/31703.
Full textAbstract:
Chronic health problems are hypothesised to be a risk factor to child and adolescent mental health, due the consistent and continuing stress these health problems pose to normative patterns of development. However, this theory remains to be substantiated by empirical research. Moreover, a systematic review conducted as part of this research indicated that the empirical body is not one on which the validity of this theory can be adequately tested. The major question posed is whether the lack of high quality epidemiological data in the field is obscuring a true psychiatric risk associated with chronic illness in childhood and adolescence, or whether, in contrast, the theory of chronic health problems as a particular risk factor to child and adolescent mental health, is based on false premises. In order to provide a stronger insight into the association of chronic health problems to mental ill-health across the late childhood and adolescent period, this study used data from a large, representative British sample (the Avon Longitudinal Study of Parents and Children (ALSPAC)) and sensitive measures of mental health outcomes. Mediating factors in these associations were also identified, and a model of the association of chronic health problems to poor mental health outcomes in early adolescence was developed. In order to ensure that all findings were applicable across chronic health conditions, outcomes over this period for children with chronic illness more generally were compared to outcomes for children with asthma diagnoses. Children with chronic health problems presented with a disproportionate rate of psychiatric illness at 10 years, and these chronic health problems continued to be associated with poor mental health outcomes across the early to mid-adolescent period. The outcomes at 10 and 13 years were suggested to be mediated by factors non-specific to any diagnosis, specifically peer victimisation and health-related school absenteeism. Limitations to external validity in the research, and implications for public health and future research are discussed.
5
Murphy, Laura Louise. "Mitochondrial trafficking in a mouse model of psychiatric illness." Thesis, University of Edinburgh, 2017. http://hdl.handle.net/1842/28882.
Full textAbstract:
Disrupted in schizophrenia 1 (DISC1), located on chromosome 1, was first identified due to its disruption by a chromosomal translocation, t(1;11)(q42;q14). This translocation co-segregates with psychiatric illness in the Scottish family within which it was discovered. DISC1 is a component of the mitochondrial trafficking machinery and regulates trafficking of mitochondria in neurons, possibly implicating defective mitochondrial trafficking as a contributory factor in psychiatric illness. The product of another candidate gene for psychiatric illness, Glycogen synthase kinase 3β (GSK3β), is known to interact directly with DISC1 and has also been reported to be involved in mitochondrial trafficking. The interaction of these proteins has not been investigated in this process. The work in this thesis centres around a novel mouse model of the t(1:11) translocation. I use time-lapse imaging of live cells to show that hippocampal neurons cultured from this mouse model exhibit altered axonal mitochondrial trafficking, including reduced mitochondrial pausing. I also demonstrate that the DISC1 interactor GSK3β is a component of the mitochondrial trafficking machinery and investigate effects of the t(1:11) event upon this multi-protein complex. Finally, I demonstrate altered mitochondrial motility responses to overexpression of GSK3β in mutant neurons. Defective mitochondrial trafficking, particularly reduced pausing, could result in an altered distribution of mitochondria within neurons, leading to an impaired ability to respond to cellular conditions, such as the requirement to power synaptic vesicle release or the ion pumps that restore membrane potential following action potential generation. This could ultimately affect neuron viability, leading to brain dysfunction. My data therefore support a proposed disease mechanism whereby defective mitochondrial trafficking contributes to susceptibility to psychiatric illness in carriers of the t(1:11) translocation, and may be relevant to psychiatric illness in general.
6
Mdleleni, Thembeka N. "Cultural construction of psychiatric illness : a case of amafufunyane." Master's thesis, University of Cape Town, 1990. http://hdl.handle.net/11427/13855.
Full textAbstract:
Bibliography: leaves 96-103.The purpose of this study was to explore definitions of an illness condition amafunyane and the subsequent help-seeking behaviour amongst Black Psychiatric patients who were attending a psychiatric community clinic in Guguletu, a residential area for Blacks in Cape Town). Psychiatrists have always been faced with the problem of having to deal with patients who present with this condition. The concern was to do an exploratory research in this area using the Explanatory Model framework as a method of enquiry in studying the condition of amafunyane. Within the parameters of this model, Black psychiatric patients presenting at the psychiatric clinic, were studied in order to explore the context of illness definitions regarding the condition of amafunyane. Of importance also was to explore the patterns of help-seeking behaviour employed by these patients, and the effect that the psychiatric orientation adopted at the clinic had on such patterns.
7
Williams, William Paul. "Aspects of a psychiatric therapeutic milieu." Thesis, University of East London, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.361850.
Full text
8
Bowersox, Nicholas W. "Treatment Attrition and Relapse Readmission in Psychiatric Inpatients: Predictors of Treatment Engagement and Psychiatric Relapse." [Milwaukee, Wis.] : e-Publications@Marquette, 2009. http://epublications.marquette.edu/dissertations_mu/18.
Full text
9
Favreau, Marie-Diane Lucie. "The pre-shrinking of psychiatry : sociological insights on the psychiatric consumer/survivor movement (1970-1992) /." Diss., Connect to a 24 p. preview or request complete full text in PDF format. Access restricted to UC IP addresses, 1999. http://wwwlib.umi.com/cr/ucsd/fullcit?p9935449.
Full text
10
Provencal, Levesque Olivia. "Category Status Conversations in the Psychiatric Context." Thesis, Université d'Ottawa / University of Ottawa, 2020. http://hdl.handle.net/10393/41505.
Full textAbstract:
Background:
Patients with mental illness often experience stigma and marginalization, which affects the quality of their healthcare. In most settings, end of life decisions, including goals of care, must be discussed with all patients upon hospital admission. This includes determining cardiopulmonary resuscitation preferences, in the event of a medical emergency. Despite this requirement, category status conversations do not routinely occur in psychiatry. It is common for psychiatric inpatients, including those at high risk for cardiac or respiratory arrest, to be admitted, cared for, and discharged without their category status known or documented. By default, patients become a ‘full code status’, which mandates life-sustaining interventions, including CPR. Unwanted interventions are often unsuccessful and inappropriate. They might also cause harm through increased pain and suffering or have no medical benefit.
Aim:
To explore how and why category status conversations occur, or do not occur, for patients admitted to psychiatry. Methods:
This was a descriptive qualitative study, with data collected through two semi-structured focus groups. Nine nurses working in psychiatry, representing two campuses of a larger tertiary care academic hospital in Ottawa, Ontario participated. Elo and Kyngäs’s approach to inductive content analysis was used to analyze the verbatim transcripts of the focus group discussions.
Findings:
Findings reveal the shared experiences of nurses initiating and engaging in category status conversations with patients admitted to psychiatry. Four overarching categories were identified: ‘The Psychiatric Culture’, ‘Being a Psychiatric Patient’, ‘Physical Health Status’, and ‘Suggestions and Recommendations’. Participants spoke about important considerations for the advancement of knowledge regarding category status conversations in psychiatry, including the nurse’s role in category status determination, the challenges of implementing a ‘one-size fits all’ approach to category status policies, and the ways in which HCPs perceptions of patients who are receiving care for depression or suicidal ideation influence these conversations in psychiatry.
Conclusion:
Nurses working in psychiatry care for patients with complex medical and psychiatric comorbidities, who are also sometimes older and frail. Category status determination for these patients is complicated and often the documented status is based on clinician presumption rather than consultation with the patient. Although the importance of completing category status conversations with patients admitted to psychiatry is known, they seldomly occur, and there is ambiguity about the nursing role within the psychiatric context. Efforts are needed to improve nurses’ contributions to category status determination for patients admitted to psychiatry, to ensure that patients’ preferences are known and upheld. Further, there are illness-related factors that complicate typical processes used to discuss and identify patient preferences, such as suicidal ideation and minimal family support. These considerations must be accounted for in hospital policy if meaningful practice change is expected.
Books on the topic "Psychiatric illness"
1
Hamilton, James Alexander, and Patricia Neel Harberger, eds. Postpartum Psychiatric Illness. Philadelphia: University of Pennsylvania Press, 1992. http://dx.doi.org/10.9783/9781512802085.
Full text
2
H, Yutzy Sean, and Goodwin Donald W, eds. Psychiatric diagnosis. 6th ed. Oxford: Oxford University Press, 2009.
Find full text
3
Mental health & mental illness. 6th ed. Philadelphia: Lippincott-Raven, 1998.
Find full text
4
1923-, Guze Samuel B., ed. Psychiatric diagnosis. 4th ed. New York: Oxford University Press, 1989.
Find full text
5
1923-, Guze Samuel B., ed. Psychiatric diagnosis. 5th ed. New York: Oxford University Press, 1996.
Find full text
6
service), SpringerLink (Online, ed. Biomarkers for Psychiatric Disorders. Boston, MA: Springer-Verlag US, 2009.
Find full text
7
Mental health and mental illness. 4th ed. Philadelphia: Lippincott, 1990.
Find full text
8
Mental health and mental illness. 5th ed. Philadelphia: J.B. Lippincott Co., 1994.
Find full text
9
1930-, Morgan Arthur James, and Morgan Arthur James 1930-, eds. Mental health and mental illness. 3rd ed. Philadelphia: Lippincott, 1985.
Find full text
10
NATO Advanced Research Workshop on Psychiatric Neuroimaging (2002 Chiavari, Italy). Psychiatric neuroimaging. Amsterdam: IOS Press, 2003.
Find full textBook chapters on the topic "Psychiatric illness"
1
Holmqvist, Maxine. "Psychiatric Illness." In Encyclopedia of Behavioral Medicine, 1552–53. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-1005-9_1172.
Full text
2
Holmqvist, Maxine. "Psychiatric Illness." In Encyclopedia of Behavioral Medicine, 1759–60. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-39903-0_1172.
Full text
3
Eisenberg, Leon. "Are Psychiatric Disorders “Real”?" In Illness Behavior, 383–90. Boston, MA: Springer US, 1986. http://dx.doi.org/10.1007/978-1-4684-5257-0_30.
Full text
4
Merskey, Harold. "Pain and Psychiatric Illness." In Clinical Pain Management, 343–48. Oxford, UK: Wiley-Blackwell, 2010. http://dx.doi.org/10.1002/9781444329711.ch41.
Full text
5
Ratcliffe, Matthew. "Empathy and psychiatric illness." In The Routledge Handbook of Philosophy of Empathy, 190–200. New York : Routledge, 2017. |: Routledge, 2017. http://dx.doi.org/10.4324/9781315282015-18.
Full text
6
Hybels, Celia F., and Dan G. Blazer. "Epidemiology of Psychiatric Illness." In The Medical Basis of Psychiatry, 671–86. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-2528-5_32.
Full text
7
Hand, D. J., and C. C. Taylor. "Neuropeptides and psychiatric illness." In Multivariate Analysis of Variance and Repeated Measures, 151–56. Dordrecht: Springer Netherlands, 1987. http://dx.doi.org/10.1007/978-94-009-3143-5_9.
Full text
8
McConnell, H. "CSF in Psychiatric Illness." In Cerebrospinal Fluid in Neurology and Psychiatry, 173–216. Boston, MA: Springer US, 1994. http://dx.doi.org/10.1007/978-1-4899-3372-0_7.
Full text
9
Guest, Paul C. "Gender and Psychiatric Disorders." In Biomarkers and Mental Illness, 127–39. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-46088-8_9.
Full text
10
Cohen, Bruce M. Z. "Introduction: Thinking Critically About Mental Illness." In Psychiatric Hegemony, 1–25. London: Palgrave Macmillan UK, 2016. http://dx.doi.org/10.1057/978-1-137-46051-6_1.
Full textConference papers on the topic "Psychiatric illness"
1
Matthews, Mark, Saeed Abdullah, Geri Gay, and Tanzeem Choudhury. "Detecting and Capitalizing on Physiological Dimensions of Psychiatric Illness." In 3rd International Conference on Physiological Computing Systems. SCITEPRESS - Science and Technology Publications, 2016. http://dx.doi.org/10.5220/0005952600980104.
Full text
2
RUBIN, ROBERT T. "THE FUNCTIONAL TOPOGRAPHY OF PSYCHIATRIC ILLNESS AS SHOWN WITH SPECT." In IX World Congress of Psychiatry. WORLD SCIENTIFIC, 1994. http://dx.doi.org/10.1142/9789814440912_0057.
Full text
3
"DUAL PATHOLOGY AND CRIMINAL BEHAVIOR IN PATIENTS CONSIDERED NOT GUILTY BY REASON OF INSANITY. A RETROSPECTIVE STUDY." In 23° Congreso de la Sociedad Española de Patología Dual (SEPD) 2021. SEPD, 2021. http://dx.doi.org/10.17579/sepd2021p124s.
Full textAbstract:
Objectives Previous studies have reported that substance misuse (including alcohol) was the strongest risk factor for violence among psychiatric diagnoses, and absolute rates of violence perpetration of over 10% in substance misuse have been found, meaning that it is an important adverse outcome for clinicians to consider. However, very few studies exist about differences in individuals considered not guilty by reason of insanity (NGRI) with only a primary psychiatric diagnosis and those with dual pathology. This study aims to compare these two groups regarding criminal history and violence. Material and Methods We analyzed a sample of 44 inpatients committed under security measure in the Forensic Psychiatry Regional Department of Lisbon’s Psychiatric Hospital Centre, after being deemed NGRI and dangerous. Data regarding previous history of substance use, psychiatric disorder and criminal history was retrospectively collected. Results and conclusions Unlike what is described in literature for other groups, in our sample of NGRI patients, dual pathology was significantly associated to having no previous violent behavior; furthermore, regarding the offense for which they were considered NGRI, patients with dual pathology were not more likely to have committed a violent crime when compared with patients with only a primary diagnosis. This may be explained because the primary illness (and not other psychosocial factors or substance misuse) was considered the primary reason for having committed the offense, and many patients were committed for domestic violence in the context of developmental disorders, an independent risk factor for violence against relatives. There was no difference between the two groups regarding other variables. Our study highlights that drug and substance misuse may be a less important factor regarding violence in the context of insanity than in other types of violence.
4
Dallmann, Petra, Rainer Leonhart, and Anja Hirschmüller. "381 Implementation of psychiatric/psychotherapeutic support within a longitudinal health monitoring in competitive para athletes." In IOC World Conference on Prevention of Injury & Illness in Sport 2021. BMJ Publishing Group Ltd and British Association of Sport and Exercise Medicine, 2021. http://dx.doi.org/10.1136/bjsports-2021-ioc.348.
Full text
5
Spinella, Toni, and Sean Barrett. "Evaluating expectancies: Do community-recruited adults believe that cannabis is an effective stress reliever?" In 2020 Virtual Scientific Meeting of the Research Society on Marijuana. Research Society on Marijuana, 2021. http://dx.doi.org/10.26828/cannabis.2021.01.000.29.
Full textAbstract:
There is growing interest in using cannabis or specific cannabinoids (e.g., THC, CBD) as therapeutic agents for various stress-related psychiatric disorders (e.g., PTSD, anxiety). While beliefs about a drug, such as expecting to feel a certain way, have strong influences over the actual effects experienced by individuals, they are rarely evaluated in clinical research. In the present exploratory report, we sought to (1) evaluate the extent to which individuals believe that cannabis relieves stress, and (2) examine whether individual characteristics (i.e., age, sex, psychiatric illness, cannabis use frequency) are related to these beliefs. A sample of 234 adults (54.7% female; Mean age=31.37, SD=11.03, 19-69 years old) from the Halifax Regional Municipality community took part in a brief telephone screening interview to assess their eligibility for a larger study (in progress). Information was gathered about the frequency of current (i.e., past month) cannabis use (days per week), the presence of current psychiatric disorder(s) ("yes"/"no"), and the extent to which they believed that cannabis was an effective stress reliever (rating scale from 1 (“not at all”) to 10 (“extremely”)). Subjects reported a mean belief rating of 6.39 (SD=2.26). A multiple regression analysis was run to evaluate whether the belief that cannabis relieves stress was related to age, sex, psychiatric illness, and frequency of current cannabis use. Overall, the model significantly predicted cannabis belief ratings (p<.001, adjusted R2=.17). Among all variables, only frequency of cannabis use contributed significantly to this prediction (B=.544, 95% CI: [.387, .701], p<.001). In general, the present sample of community-recruited adults believed that cannabis was somewhat effective at relieving stress. Additionally, cannabis use frequency was the only variable that predicted the strength of this belief, such that more frequent use was associated with higher belief ratings. This is consistent with prior research indicating that heavier cannabis use is linked to positive cannabis expectancies. Given that stimulus expectancies influence substance-related responses, such findings would further the case for evaluating and controlling for these expectancies in clinical work with cannabis for stress-related conditions. Indeed, clinical cannabis research evaluating samples of heavy or frequent cannabis users may be subject to bias due to higher positive expectancies.
6
Alotaibi, Raied, Laura Bijman, Nynke Halbesma, Gareth Clegg, and Caroline Jackson. "P76 Incidence, outcomes and characteristics of out-of-hospital cardiac arrests in patients with psychiatric illness: a systematic review." In Society for Social Medicine Annual Scientific Meeting Abstracts. BMJ Publishing Group Ltd, 2021. http://dx.doi.org/10.1136/jech-2021-ssmabstracts.164.
Full text
7
Khaled, Salma, Peter Haddad, Majid Al-Abdulla, Tarek Bellaj, Yousri Marzouk, Youssef Hasan, Ibrahim Al-Kaabi, et al. "Qatar - Longitudinal Assessment of Mental Health in Pandemics (Q-LAMP)." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0287.
Full textAbstract:
Aims: Q-LAMP aims to identify risk factors and resilience factors for symptoms of psychiatric illness during the pandemic. Study strengths include the 1-year longitudinal design and the use of standardized instruments already available in English and Arabic. The results will increase understanding of the impact of the pandemic on mental health for better support of the population during the pandemic and in future epidemics. Until an effective vaccine is available or herd immunity is achieved, countries are likely to encounter repeated ‘waves’ of infection. The identification of at-risk groups for mental illness will inform the planning and delivery of individualized treatment including primary prevention. Methodology: Longitudinal online survey; SMS-based recruitment and social media platforms advertisements e.g. Facebook, Instagram; Online consent; Completion time for questionnaires: approx. 20 to 30 minute; Baseline questionnaire with follow up at 3, 6, 9 and 12 months; Study completion date: Sept. 2021. Inclusion criteria: Currently living in Qatar; Qatari residents: citizens and expatriates; Age 18 years; read Arabic or English (questionnaire and consent form available in both languages). Instruments: Sociodemographic questionnaire including personal and family experience of COVID-19 infection; Standard instruments to assess psychiatric morbidity including depression, anxiety and PTSD; research team-designed instruments to assess social impact of pandemic; standard questionnaires to assess resilience, personality, loneliness, religious beliefs and social networks. Results: The analysis was based on 181 observations. Approximately, 3.5% of the sample was from the sms-recruitment method. The sample of completed surveys consisted of 65.0% females and 35.0% males. Qatari respondents comprised 27.0% of the total sample, while 52% of the sample were married, 25% had Grade 12 or lower level of educational attainment, and 46.0% were unemployed. Covid-19 appears to have affected different aspects of people’s lives from personal health to living arrangements, employment, and health of family and friends. Approximately, 41% to 55% of those who responded to the survey perceived changes in their stress levels, mental health, and loneliness to be worse than before the pandemic. Additionally, the wide availability of information about the pandemic on the internet and social media was perceived as source of pandemic-related worries among members of the public. Conclusion: The continued provision of mental health service and educational campaigns about effective stress and mental health management is warranted.
8
Monika, Ulrichova, and Brichova Marie. "Some Aspects of the Impact that Children (Being Treated at a Psychiatric Illness) have Upon the Quality of Life of their Parents." In 2016 2nd International Conference on Humanities and Social Science Research (ICHSSR 2016). Paris, France: Atlantis Press, 2016. http://dx.doi.org/10.2991/ichssr-16.2016.49.
Full text
9
Santos, Trinnye Luizze, Paula Drumond Batista de Oliveira, Maria Paula Travasso Oliveira, Gustavo Henrique Duarte de Morais, Bruna Carolina Rangel Fortes, Darina Andrade Addario Rizzardi, Milena Gonçalves Guerreiro, Silvia Regina Seibel De Matos, and Milena Marques. "Clinical prognosis of Charles Bonnet Syndrome: A review of Integrative Literature." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.143.
Full textAbstract:
Background: Charles Bonnet syndrome (CBS) is defined by repetitive experiences of visual hallucinations. This classically affects the elderly with visual impairment, intact cognition and the absence of psychiatric illness. Hallucinations remain indefinitely and can be static, dynamic, elementary or complex, colored or in black and white, centrally or peripherally. Objectives: To analyze the scientific information available on the clinical aspects of CBS. Methods: A bibliographic review was carried out in the PubMed database, in the last 10 years, using the descriptors “Charles Bonnet Syndrome”, “Hallucinations” and “Prognosis”, associated with the Boolean operator “AND’’. English and Portuguese were included, inconclusive studies were excluded, with biases or duplicates, whose approaches did not indicate an outcome in the syndrome, selecting 12 articles. Results: It was observed that there is no consensus on the pathophysiology and age range of CBS involvement, which varies between 70 and 80. The incidence is up to 1.4%. As for the prognosis, one of the articles pointed to the presence of hallucinations between 7 and 18 months, these varying in complexity, frequency and impact on patients’ lives. Diagnosis is made by exclusion, emphasizing the benign character, assertive diagnosis and effective treatment are essential factors for the mild evolution of the disorder. Conclusion: As it is considered a rare disease, it is rarely addressed in the literature and, therefore, new studies are desirable, in order to demystify the condition and ensure an appropriate approach to patients.
10
Coratu, Ana Maria, Gerard Angel Mateu Codina, Rebeca Alayon Santana, Rosa Blanca Sauras Quetcuti, Marta Torrens Melich, and Lina Maria Oviedo Penuela. "PSYCHOTIC DISORDERS IN PATIENTS WITH SUBSTANCE USE A descriptive study of patients attended in a Dual Pathology Department." In 22° Congreso de la Sociedad Española de Patología Dual (SEPD) 2020. SEPD, 2020. http://dx.doi.org/10.17579/sepd2020p044.
Full textAbstract:
a) Objectives: This study analyses the characteristics and prevalence of psychotic disorders in patients with substance use, that needed medical and psychiatric care in a Dual Pathology Department during a 3 years period. b) Background and aims: The strong comorbidity between substance use and psychotic disorders has been deeply studied in recent literature. The aim of this study is to analyse the characteristics of the psychotic episode (primary or drug-induced), the predominant substance of use and the age of onset of consumption, as well as some sociodemographic characteristics in these patients. c) Materials and methods After a bibliographic review of recent literature, we realize a descriptive study of psychotic disorders and substance use from a total of 531 hospitalized patients during a 3 years period, using SPSS for Windows 20.0 database for statistic results. d) Results: In this study we can observe a predominant percentage of males with an average age of 36 years old, around 50% psychotic disorders out of total number of patients with a predominant type of primary psychosis and a high prevalence of cocaine (18% of total patients), alcohol (16%) and cannabis (8%) use and also an early age of onset of problematic consumption (15 years old for alcohol, 16 years old for cannabis and 21 years old for cocaine). e) Conclusions: The result of this study approach the current literature data about psychotic disorders and substance use and underlines the importance of a correct and early diagnosis in patients with a serious mental illness.
Reports on the topic "Psychiatric illness"
1
Madu, Laura, Jacqueline Sharp, and Bobby Bellflower. Efficacy of Integrating CBT for Mental Health Care into Substance Abuse Treatment in Patients with Comorbid Disorders of Substance Abuse and Mental Illness. University of Tennessee Health Science Center, April 2021. http://dx.doi.org/10.21007/con.dnp.2021.0004.
Full textAbstract:
Abstract: Multiple studies have found that psychiatric disorders, like mood disorders and substance use disorders, are highly comorbid among adults with either disorder. Integrated treatment refers to the treatment of two or more conditions and the use of multiple therapies such as the combination of psychotherapy and pharmacotherapy. Integrated therapy for comorbidity per numerous studies has consistently been superior to the treatment of individual disorders separately. The purpose of this QI project was to identify the effectiveness of Cognitive Behavioral Therapy (CBT) instead of current treatment as usual for treating Substance Use Disorder (SUD) or mental health diagnosis independently. It is a retrospective chart review. The review examines CBT's efficacy for engaging individuals with co-occurring mood and substance u se disorders in treatment by enhancing adherence and preventing disengagement and relapse. Methods: Forty adults aged 26-55 with a DSM-IV diagnosis of a mood disorder of Major Depressive Disorder and/or anxiety and concurrent substance use disorder (at least weekly use in the past month). Participants received 12 sessions of individual integrated CBT treatment delivered with case management over a 12-week period. Results: The intervention was associated with significant improvements in mood disorder, substance use, and coping skills at 4, 8, and 12 weeks post-treatment. Conclusions: These results provide some evidence for the effectiveness of the integrated CBT intervention in individuals with co-occurring disorders. Of note, all psychotherapies are efficacious; however, it would be more advantageous to develop a standardized CBT that identifies variables that facilitate treatment outcomes specifically to comorbid disorders of substance use and mood disorders. It is concluded that there is potentially more to be gained from further studies using randomized controlled designs to determine its efficacy.
2
Viswanathan, Meera, Jennifer Cook Middleton, Alison Stuebe, Nancy Berkman, Alison N. Goulding, Skyler McLaurin-Jiang, Andrea B. Dotson, et al. Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Systematic Review of Perinatal Pharmacologic Interventions. Agency for Healthcare Research and Quality (AHRQ), April 2021. http://dx.doi.org/10.23970/ahrqepccer236.
Full textAbstract:
Background. Untreated maternal mental health disorders can have devastating sequelae for the mother and child. For women who are currently or planning to become pregnant or are breastfeeding, a critical question is whether the benefits of treating psychiatric illness with pharmacologic interventions outweigh the harms for mother and child. Methods. We conducted a systematic review to assess the benefits and harms of pharmacologic interventions compared with placebo, no treatment, or other pharmacologic interventions for pregnant and postpartum women with mental health disorders. We searched four databases and other sources for evidence available from inception through June 5, 2020 and surveilled the literature through March 2, 2021; dually screened the results; and analyzed eligible studies. We included studies of pregnant, postpartum, or reproductive-age women with a new or preexisting diagnosis of a mental health disorder treated with pharmacotherapy; we excluded psychotherapy. Eligible comparators included women with the disorder but no pharmacotherapy or women who discontinued the pharmacotherapy before pregnancy. Results. A total of 164 studies (168 articles) met eligibility criteria. Brexanolone for depression onset in the third trimester or in the postpartum period probably improves depressive symptoms at 30 days (least square mean difference in the Hamilton Rating Scale for Depression, -2.6; p=0.02; N=209) when compared with placebo. Sertraline for postpartum depression may improve response (calculated relative risk [RR], 2.24; 95% confidence interval [CI], 0.95 to 5.24; N=36), remission (calculated RR, 2.51; 95% CI, 0.94 to 6.70; N=36), and depressive symptoms (p-values ranging from 0.01 to 0.05) when compared with placebo. Discontinuing use of mood stabilizers during pregnancy may increase recurrence (adjusted hazard ratio [AHR], 2.2; 95% CI, 1.2 to 4.2; N=89) and reduce time to recurrence of mood disorders (2 vs. 28 weeks, AHR, 12.1; 95% CI, 1.6 to 91; N=26) for bipolar disorder when compared with continued use. Brexanolone for depression onset in the third trimester or in the postpartum period may increase the risk of sedation or somnolence, leading to dose interruption or reduction when compared with placebo (5% vs. 0%). More than 95 percent of studies reporting on harms were observational in design and unable to fully account for confounding. These studies suggested some associations between benzodiazepine exposure before conception and ectopic pregnancy; between specific antidepressants during pregnancy and adverse maternal outcomes such as postpartum hemorrhage, preeclampsia, and spontaneous abortion, and child outcomes such as respiratory issues, low Apgar scores, persistent pulmonary hypertension of the newborn, depression in children, and autism spectrum disorder; between quetiapine or olanzapine and gestational diabetes; and between benzodiazepine and neonatal intensive care admissions. Causality cannot be inferred from these studies. We found insufficient evidence on benefits and harms from comparative effectiveness studies, with one exception: one study suggested a higher risk of overall congenital anomalies (adjusted RR [ARR], 1.85; 95% CI, 1.23 to 2.78; N=2,608) and cardiac anomalies (ARR, 2.25; 95% CI, 1.17 to 4.34; N=2,608) for lithium compared with lamotrigine during first- trimester exposure. Conclusions. Few studies have been conducted in pregnant and postpartum women on the benefits of pharmacotherapy; many studies report on harms but are of low quality. The limited evidence available is consistent with some benefit, and some studies suggested increased adverse events. However, because these studies could not rule out underlying disease severity as the cause of the association, the causal link between the exposure and adverse events is unclear. Patients and clinicians need to make an informed, collaborative decision on treatment choices.
3
MacFarlane, Andrew. 2021 medical student essay prize winner - A case of grief. Society for Academic Primary Care, July 2021. http://dx.doi.org/10.37361/medstudessay.2021.1.1.
Full textAbstract:
As a student undertaking a Longitudinal Integrated Clerkship (LIC)1 based in a GP practice in a rural community in the North of Scotland, I have been lucky to be given responsibility and my own clinic lists. Every day I conduct consultations that change my practice: the challenge of clinically applying the theory I have studied, controlling a consultation and efficiently exploring a patient's problems, empathising with and empowering them to play a part in their own care2 – and most difficult I feel – dealing with the vast amount of uncertainty that medicine, and particularly primary care, presents to both clinician and patient. I initially consulted with a lady in her 60s who attended with her husband, complaining of severe lower back pain who was very difficult to assess due to her pain level. Her husband was understandably concerned about the degree of pain she was in. After assessment and discussion with one of the GPs, we agreed some pain relief and a physio assessment in the next few days would be a practical plan. The patient had one red flag, some leg weakness and numbness, which was her ‘normal’ on account of her multiple sclerosis. At the physio assessment a few days later, the physio felt things were worse and some urgent bloods were ordered, unfortunately finding raised cancer and inflammatory markers. A CT scan of the lung found widespread cancer, a later CT of the head after some developing some acute confusion found brain metastases, and a week and a half after presenting to me, the patient sadly died in hospital. While that was all impactful enough on me, it was the follow-up appointment with the husband who attended on the last triage slot of the evening two weeks later that I found completely altered my understanding of grief and the mourning of a loved one. The husband had asked to speak to a Andrew MacFarlane Year 3 ScotGEM Medical Student 2 doctor just to talk about what had happened to his wife. The GP decided that it would be better if he came into the practice - strictly he probably should have been consulted with over the phone due to coronavirus restrictions - but he was asked what he would prefer and he opted to come in. I sat in on the consultation, I had been helping with any examinations the triage doctor needed and I recognised that this was the husband of the lady I had seen a few weeks earlier. He came in and sat down, head lowered, hands fiddling with the zip on his jacket, trying to find what to say. The GP sat, turned so that they were opposite each other with no desk between them - I was seated off to the side, an onlooker, but acknowledged by the patient with a kind nod when he entered the room. The GP asked gently, “How are you doing?” and roughly 30 seconds passed (a long time in a conversation) before the patient spoke. “I just really miss her…” he whispered with great effort, “I don’t understand how this all happened.” Over the next 45 minutes, he spoke about his wife, how much pain she had been in, the rapid deterioration he witnessed, the cancer being found, and cruelly how she had passed away after he had gone home to get some rest after being by her bedside all day in the hospital. He talked about how they had met, how much he missed her, how empty the house felt without her, and asking himself and us how he was meant to move forward with his life. He had a lot of questions for us, and for himself. Had we missed anything – had he missed anything? The GP really just listened for almost the whole consultation, speaking to him gently, reassuring him that this wasn’t his or anyone’s fault. She stated that this was an awful time for him and that what he was feeling was entirely normal and something we will all universally go through. She emphasised that while it wasn’t helpful at the moment, that things would get better over time.3 He was really glad I was there – having shared a consultation with his wife and I – he thanked me emphatically even though I felt like I hadn’t really helped at all. After some tears, frequent moments of silence and a lot of questions, he left having gotten a lot off his chest. “You just have to listen to people, be there for them as they go through things, and answer their questions as best you can” urged my GP as we discussed the case when the patient left. Almost all family caregivers contact their GP with regards to grief and this consultation really made me realise how important an aspect of my practice it will be in the future.4 It has also made me reflect on the emphasis on undergraduate teaching around ‘breaking bad news’ to patients, but nothing taught about when patients are in the process of grieving further down the line.5 The skill Andrew MacFarlane Year 3 ScotGEM Medical Student 3 required to manage a grieving patient is not one limited to general practice. Patients may grieve the loss of function from acute trauma through to chronic illness in all specialties of medicine - in addition to ‘traditional’ grief from loss of family or friends.6 There wasn’t anything ‘medical’ in the consultation, but I came away from it with a real sense of purpose as to why this career is such a privilege. We look after patients so they can spend as much quality time as they are given with their loved ones, and their loved ones are the ones we care for after they are gone. We as doctors are the constant, and we have to meet patients with compassion at their most difficult times – because it is as much a part of the job as the knowledge and the science – and it is the part of us that patients will remember long after they leave our clinic room. Word Count: 993 words References 1. ScotGEM MBChB - Subjects - University of St Andrews [Internet]. [cited 2021 Mar 27]. Available from: https://www.st-andrews.ac.uk/subjects/medicine/scotgem-mbchb/ 2. Shared decision making in realistic medicine: what works - gov.scot [Internet]. [cited 2021 Mar 27]. Available from: https://www.gov.scot/publications/works-support-promote-shared-decisionmaking-synthesis-recent-evidence/pages/1/ 3. Ghesquiere AR, Patel SR, Kaplan DB, Bruce ML. Primary care providers’ bereavement care practices: Recommendations for research directions. Int J Geriatr Psychiatry. 2014 Dec;29(12):1221–9. 4. Nielsen MK, Christensen K, Neergaard MA, Bidstrup PE, Guldin M-B. Grief symptoms and primary care use: a prospective study of family caregivers. BJGP Open [Internet]. 2020 Aug 1 [cited 2021 Mar 27];4(3). Available from: https://bjgpopen.org/content/4/3/bjgpopen20X101063 5. O’Connor M, Breen LJ. General Practitioners’ experiences of bereavement care and their educational support needs: a qualitative study. BMC Medical Education. 2014 Mar 27;14(1):59. 6. Sikstrom L, Saikaly R, Ferguson G, Mosher PJ, Bonato S, Soklaridis S. Being there: A scoping review of grief support training in medical education. PLOS ONE. 2019 Nov 27;14(11):e0224325.
4
In Conversation… Parental Mental Illness. ACAMH, August 2018. http://dx.doi.org/10.13056/acamh.4621.
Full textAbstract:
In this podcast, Dr Alan Cooklin and Jessica Streeting discuss the impact of parental mental illness, how family psychiatry has developed, how everyone has a key role to play, and the power of explanation and understanding as a protective intervention.